- Amgen adds $300M to Puerto Rico budget; Novartis to exit oral drug factory in GermanyPlus, news about FDA's one-day inspections and BioMADE: 🇵🇷 Amgen pours another $300M into Puerto Rico: The funds will be used to bolster its biologics production in Juncos, which was establishe…Endpoints · 2mo ago↗ source
- Atara, Pierre Fabre's cell therapy to get another shot at FDA approvalThere's new life for a twice-rejected T cell therapy from Atara Biotherapeutics and Pierre Fabre Pharmaceuticals. US regulators are willing to reconsider using a Phase 3 study as the basis for an…Endpoints · 2mo ago↗ source
- <![CDATA[Track the Lung Cancer Abstracts That are Gaining Attention at ASCO 2026]]><![CDATA[Read on to see what data are poised to shape clinical discussions and decision-making in lung cancer at 2026 ASCO Annual Meeting in Chicago, Illinois.]]>